Congressional Research Service Foresees Potential DEA Endorsement Of Marijuana Rescheduling

By Joana Scopel

On August 29, 2023, the U.S. Department of Health and Human Services (HHS) recommended the DEA reclassify marijuana and move it from Schedule I to Schedule III, following a review by the Food and Drug Administration (FDA), as part of a process initiated by Presiden

You are viewing a robot-friendly page.Click hereto reload in standard format.